It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
Zydus' Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
CuraTeQ Biologics is on track for filing a second oncology biosimilar
The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
Subscribe To Our Newsletter & Stay Updated
